Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

4. august 2026 opdateret af: Shaklee Corporation

An Observational, Cross-Sectional Study Evaluating the Impact of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge Trial

This study will evaluate whether dietary supplement use (> 1 year) is associated with differences in biological age relative to chronological age, as well as differences in metabolic health and functional fitness tests.

Studieoversigt

Detaljeret beskrivelse

Using a cross-sectional study design, information will be obtained by biomarker analysis, questionnaires, physical examination, and physical function from a convenience sample of long-term users of dietary supplements. Comparison data for non-users and single multivitamin/mineral and multiple supplement users will be obtained from the National Health and Nutrition Examination Survey (NHANES).

Undersøgelsestype

Observationel

Tilmelding (Anslået)

300

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Illinois
      • Addison, Illinois, Forenede Stater, 60101
        • Rekruttering
        • Biofortis Clinical Research

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Participants will be recruited from a database of long-term Sponsor supplement users.

Beskrivelse

Inclusion Criteria:

  • Adults aged 40 years or older.
  • Verified long-term Sponsor supplement use (>1 year).
  • Willing and able to provide informed consent and comply with study procedures.
  • Able to fast overnight (>8 hours) prior to the study visit.
  • Willing and able to travel to the test site.
  • Ambulatory and currently free of injury or other physical impairment that hinders mobility.
  • Willing to use a personal smart phone or computer with internet access and active email address.
  • Willing to adhere to all study procedures and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information.

Exclusion Criteria:

  • Current or recent (within 6 months) diagnosis of cancer except for non-melanoma skin cancer.
  • Participant is pregnant or lactating.
  • Participant has a pacemaker or other implanted electronic device.
  • Any condition the study staff believes would interfere with the participant's ability to provide informed consent or comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Generally healthy adults, 40 years of age and older, who are long-term (>1 year) supplement users
Participants will be long-term users (>1 year) of the Sponsors supplement products
Ingen intervention: observationskohorte

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Difference between biological and chronological age (years) calculated using a validated biological age calculator
Tidsramme: Baseline single assessment for this observational study
Differences will be compared to an NHANES cohort, where possible.
Baseline single assessment for this observational study

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Blood pressure (mm Hg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Heart rate (beats per minute)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body weight (kg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body mass index (kg/m2)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Waist-to-hip ratio
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Body fat (%)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Fat-free body mass (kg)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Grip strength (kg)
Tidsramme: Single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Single assessment for this observational study
Lower body strength assessed using the chair stand test (total number of stands)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Flexibility assessed using the sit and reach test (distance in inches reached)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Balance assessed using the one-legged stance test (hold time in seconds)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Quality of life as assessed by the CDC HRQOL-4 questionnaire (overall health rating and number of days)
Tidsramme: Single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Single assessment for this observational study
Cognition as assessed by the cognition scale of the Fatigue and Altered Cognition Scale questionnaire (cognition scale total score)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study
Social connection as assessed by the NIH Social Connection and Isolation Panel questionnaire (total score)
Tidsramme: Baseline single assessment for this observational study
Differences will be assessed in comparison to an NHANES cohort
Baseline single assessment for this observational study

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Erin Barrett, PhD, Shaklee Corporation

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

12. maj 2026

Primær færdiggørelse (Anslået)

1. august 2026

Studieafslutning (Anslået)

1. august 2026

Datoer for studieregistrering

Først indsendt

23. juni 2026

Først indsendt, der opfyldte QC-kriterier

4. august 2026

Først opslået (Faktiske)

10. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • BIO-2607

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner